Mszycol en es it fr

Mszycol Brand names, Mszycol Analogs

Mszycol Brand Names Mixture

  • No information avaliable

Mszycol Chemical_Formula

C24H31ClO7

Mszycol RX_link

http://www.rxlist.com/cgi/generic2/lotemax.htm

Mszycol fda sheet

Mszycol FDA

Mszycol msds (material safety sheet)

Mszycol MSDS

Mszycol Synthesis Reference

No information avaliable

Mszycol Molecular Weight

466.951 g/mol

Mszycol Melting Point

220-224 oC

Mszycol H2O Solubility

5 mg/mL

Mszycol State

Solid

Mszycol LogP

4.004

Mszycol Dosage Forms

Solution; Spray

Mszycol Indication

As an ophthalmic it is used for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, used for the treatment and management of seasonal allergic rhinitis.

Mszycol Pharmacology

Loteprednol etabonate (LE) is a "soft" steroid belonging to a unique class of glucocorticoids. LE possesses a metabolically labile 17 beta-chloromethyl ester function which was designed in order to be hydrolyzed to an inactive carboxylic acid moiety. This inactive metabolite is more hydrophilic and is thus readily eliminated from the body. Loteprednol etabonate has good ocular permeation properties and good skin permeation properties similar to "hard" steroids. It is used as a topical agent for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis and iritis.

Mszycol Absorption

Very limited systemic absorption, but good absorption at the point of delivery.

Mszycol side effects and Toxicity

Adverse effects include abnormal vision / blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia.

Mszycol Patient Information

Mszycol Organisms Affected

Humans and other mammals